Status:

TERMINATED

AO Multicenter Intervention Trial for Prevention of Surgical Site Infection

Lead Sponsor:

AO Clinical Investigation and Publishing Documentation

Conditions:

Surgical Site Infection

Eligibility:

All Genders

18-100 years

Phase:

NA

Brief Summary

This study is designed to collect data from 8,476 fracture patients during a pre-and post-intervention phases of two years length each. The intervention consists on the implementation of the AOT SSI P...

Detailed Description

During the first phase of the study, 4,238 patients will be recruited and the baseline incidence of surgical site infection at each participating site will be determined. At the beginning of the third...

Eligibility Criteria

Inclusion

  • • Age \> 18 years
  • Recent fracture (\< 10 days) located in femur, tibia or humerus
  • Any type of open or closed fracture
  • Produced by high or low energy trauma
  • Primary fracture treatment with surgery and use of any of the following:
  • Intramedullary or extramedullary devices including cases in which a temporary external fixator is used
  • Joint replacement
  • Informed consent obtained (if required by local EC/IRB), i.e.:
  • Ability to understand the content of the patient information/ICF
  • Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
  • Signed and dated EC/IRB approved written informed consent

Exclusion

  • Pathologic fracture secondary to tumors, infection or cysts
  • Patients with an underlying chronic, bone and joint infection or prior history of a bone and joint infection
  • Refracture and non-union
  • Peri-implant fractures
  • Patients with terminal illness
  • Pregnancy or women planning to conceive within the study period
  • Prisoner
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Key Trial Info

Start Date :

December 6 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2021

Estimated Enrollment :

222 Patients enrolled

Trial Details

Trial ID

NCT03380273

Start Date

December 6 2019

End Date

December 31 2021

Last Update

January 18 2022

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

1

Cedars Sinai Medical Center

Los Angeles, California, United States, 90048

2

University of Kentucky Healthcare

Lexington, Kentucky, United States, 40536-0284

3

UMass Memorial Medical Center

Worcester, Massachusetts, United States, 01655

4

Missouri Orthopaedic Institute

Columbia, Missouri, United States, 65212